Mechanisms of NLRP3 inflammasome in pathogenesis and progression of inflammation-related gastrointestinal diseases
PeerJ · 2025
DOI: 10.7717/peerj.19828 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PeerJ, 2025. Verfasst von Fengmei Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, 905th Hospital of People's Liberation Army Navy, Shanghai, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Gastrointestinal Diseases, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The inflammasome is a novel component of the innate immune response. It plays a crucial role in the pathogenesis and progression of inflammation-related gastrointestinal diseases. Among various inflammasomes, the NLR family pyrin domain containing 3 (NLRP3) inflammasome is one of the most extensively studied. Increasingly, researchers are exploring its roles and mechanisms, particularly in inflammation-immune-related diseases. As a result, a review paper is demanded to review and summarize the previous and latest studies on the role and mechanisms of NLRP3 inflammasome in pathogenesis and progression of inflammation-related gastrointestinal diseases. This review comprehensively elaborates on the biological characteristics of the NLRP3 inflammasome, including its assembly and activation mechanisms. Additionally, it emphasizes the roles and mechanisms of the NLRP3 inflammasome in common inflammation-related gastrointestinal diseases such as ulcerative colitis, Crohn’s disease, pancreatitis, and non-alcoholic fatty liver disease (NAFLD). Furthermore, the application of NLRP3 inflammasome inhibitors in treating these diseases is discussed. Articles from PubMed and Web of Science on NLRP3 inflammasome, ulcerative colitis, Crohn’s disease, pancreatitis, and NAFLD were summarized to analyze the data and conclusions carefully to ensure the comprehensiveness, completeness, and accuracy of the review. This study aims to provide scholars engaged in research on gastrointestinal diseases with new directions for developing more effective therapeutics for inflammation-related gastrointestinal diseases by investigating the NLRP3 inflammasome’s role in these conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nursing, 905th Hospital of People's Liberation Army Navy, Shanghai, China.
- Department of Gastroenterology, Chinese PLA General Hospital, Beijing, China.
- Center of Digestive Endoscopy, 905th Hospital of People's Liberation Army Navy, Shanghai, China.
- Department of Pharmacy, 905th Hospital of People's Liberation Army Navy, Shanghai, China.
- Department of Gastroenterology, 905th Hospital of People's Liberation Army Navy, Shanghai, China.
Zitieren
APA
Liu, F., Shao, B., Zhu, Y., Xue, X., & Wu, X. (2025). Mechanisms of NLRP3 inflammasome in pathogenesis and progression of inflammation-related gastrointestinal diseases. PeerJ. https://doi.org/10.7717/peerj.19828
Vancouver
Liu F, Shao B, Zhu Y, Xue X, Wu X. Mechanisms of NLRP3 inflammasome in pathogenesis and progression of inflammation-related gastrointestinal diseases. PeerJ. 2025. doi:10.7717/peerj.19828
BibTeX
@article{Liu2025,
author = {Liu, Fengmei and Shao, Bozong and Zhu, Yaqin and Xue, Xiaochun and Wu, Xiaoyan},
title = {Mechanisms of NLRP3 inflammasome in pathogenesis and progression of inflammation-related gastrointestinal diseases},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.19828}
}
EUVIMED